Fig. 1

a-c Scatter plots representing pre-chemotherapy plasma levels of EpCAM+ EVs (a), CD45+ EVs (b) and double positive EpCAM+CD45+ EVs (c) in platinum-sensitive (n=17), platinum-resistant (n=6) and platinum-refractory (n=5) patients. a Pre-chemotherapy plasma levels of EpCAM+ EVs across patients’ groups. b Pre-chemotherapy plasma levels of CD45+ EVs across patients’ groups. c Pre-chemotherapy plasma levels of double-positive EpCAM+CD45+EVs across patients’ groups. Results are expressed as mean +/- SD or median, according to type of variables. Pre: pre-chemotherapy; Post: post chemotherapy; * p<0.05; **p<0.01